tiprankstipranks
Edwards Lifesciences Enhances Shareholder Value Post-Divestiture
Company Announcements

Edwards Lifesciences Enhances Shareholder Value Post-Divestiture

Don't Miss our Black Friday Offers:

Edwards Lifesciences (EW) has provided an announcement.

Edwards Lifesciences Corporation has successfully completed the sale of its Critical Care product group to Becton, Dickinson and Company. Following the sale, the company’s Board of Directors has approved an additional $1.5 billion for share repurchases, alongside entering into a $500 million accelerated share repurchase agreement. This move signifies a strategic shift and a potential return of value to shareholders.

Learn more about EW stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTrump Trade: President-elect seeks to kill Biden fuel-efficiency rules
TheFlyEdwards Lifesciences call volume above normal and directionally bullish
TheFlyEdwards Lifesciences call volume above normal and directionally bullish
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App